| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.08 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |